Nerivio® Impact on Migraine Treatment Highlighted in 3 Real-World Studies
Theranica presented three new real-world studies on their Nerivio® REN wearable at the 2025 American Headache Society meeting. The...
eClinical Tech News
Biomea Fusion’s BMF-650 Shows Strong Weight Loss, Appetite Suppression in Preclinical Primate Study
Biomea Fusion announced positive preclinical results for BMF-650, an oral GLP-1 receptor agonist for obesity, in a 28-day study...
Senti-202: FDA Grants Orphan Drug Designation for AML Treatment
Senti Biosciences announced that the FDA granted Orphan Drug Designation to SENTI-202 for relapsed/refractory hematologic malignancies, including acute myeloid...
Axsome to Present Symbravo Data at American Headache Society Meeting
Axsome Therapeutics announced that data from the SYMBRAVO (meloxicam and rizatriptan) clinical program will be presented at the 67th...
Eolo Pharma’s Novel Obesity Drug Activates Energy-Burning Pathway
Eolo Pharma announced positive results from its first-in-human study of SANA, a novel drug targeting creatine-dependent thermogenesis for obesity...
NorthStrive Biosciences Initiates Phase II of AI-Powered Therapy Collaboration
Northstrive Biosciences, a subsidiary of PMGC Holdings Inc., has initiated Phase II of its AI drug development program with...
Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy
The FDA granted Orphan Drug Designation to Capricor Therapeutics’ Deramiocel for treating Becker Muscular Dystrophy (BMD). This designation expands...
Ventyx Biosciences Positive Top-Line Data for Parkinson’s
Ventyx Biosciences announced positive top-line results from its Phase 2a study of VTX3232, an oral NLRP3 inhibitor, in patients...
Centessa Announces IND Clearance for Novel OX2R Agonist, ORX142
Centessa Pharmaceuticals has received FDA clearance to begin a Phase 1 clinical trial of ORX142, a new OX2R agonist,...
Micron and Emory Launch Trial of Next-Gen Rotavirus Vaccine
Emory University and Micron Biomedical have launched the first clinical trial of a rotavirus vaccine, CC24, delivered via dissolvable...